These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17875784)

  • 21. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines.
    Salem ML
    Int Immunopharmacol; 2005 Jun; 5(6):947-60. PubMed ID: 15829411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
    Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
    Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
    Almqvist Y; Steffen AC; Tolmachev V; Divgi CR; Sundin A
    Nucl Med Biol; 2006 Nov; 33(8):991-8. PubMed ID: 17127172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
    Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
    Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells.
    Neufing PJ; Clancy RM; Jackson MW; Tran HB; Buyon JP; Gordon TP
    Arthritis Rheum; 2005 Dec; 52(12):3934-42. PubMed ID: 16320341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model.
    Marecos E; Weissleder R; Bogdanov A
    Bioconjug Chem; 1998; 9(2):184-91. PubMed ID: 9548533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment of EL4 tumor-bearing mouse models and investigation on immunological mechanisms of anti-tumor effect of melphalan].
    Li ML; Li CG; Shu XH; Jia YJ; Qin ZH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):235-8. PubMed ID: 16507262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
    Wang F; Fang W; Ji SD; Meng QL; Li Y; Fan KW; Wang ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.
    Honeychurch J; Glennie MJ; Illidge TM
    Cancer Res; 2005 Aug; 65(16):7493-501. PubMed ID: 16103104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
    Du Y; Honeychurch J; Glennie M; Johnson P; Illidge T
    Cancer Res; 2007 Feb; 67(3):1335-43. PubMed ID: 17283171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.
    Kemp CJ; Sun S; Gurley KE
    Cancer Res; 2001 Jan; 61(1):327-32. PubMed ID: 11196181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
    Zaleskis G; Ho RL; Diegelman P; Maccubbin D; Ujházy P; Mihich E; Ehrke MJ
    Oncol Res; 1994; 6(4-5):183-94. PubMed ID: 7841541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.
    Supiot S; Gouard S; Charrier J; Apostolidis C; Chatal JF; Barbet J; Davodeau F; Cherel M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7047s-7052s. PubMed ID: 16203801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.